NYXH
Nyxoah SA
Price Chart
Latest Quote
$1.62
+0.01 (+0.62%)
Current Price
| Previous Close | $1.61 |
| Open | $1.59 |
| Day High | $1.63 |
| Day Low | $1.59 |
| Volume | 18,023 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 100.07M |
| Total Debt | $41.30M |
| Cash Equivalents | $29.68M |
| Revenue | $17.54M |
| Net Income | $-95.74M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $157.11M |
| EPS (TTM) | $-2.43 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $78.70M |
| Sales | $17.54M |
| Income | $-95.74M |
| Book/sh | $0.94 |
| Cash/sh | $0.26 |
| Employees | 153 |
Financial Ratios
| Quick Ratio | 0.85 |
| Current Ratio | 0.99 |
| Debt/Eq | 100.58 |
Returns & Margins
| ROA | -44.59% |
| ROE | -129.97% |
| Gross Margin | 60.71% |
| Operating Margin | -321.72% |
Ownership
| Insider Ownership | 33.78% |
| Institutional Ownership | 26.81% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.29 |
| P/S | 10.25 |
| P/B | 1.68 |
Analyst Data
| Recommendation | buy |
| Target Price | $8.39 |
Technical Indicators
| SMA20 | $1.65 |
| SMA50 | $2.18 |
| SMA200 | $3.87 |
| RSI | 41.94 |
| ATR | 0.1098 |
| Shares Float | 29.75M |
| Short Float | 0.34% |
| Short Ratio | 0.43 |
| Volatility | 0.96 |
| Rel Volume | 0.64 |
Performance History
| Week | -8.19% |
| Month | -0.63% |
| Quarter | -52.13% |
| 6 Months | -69.34% |
| YTD | -65.11% |
| Year | -80.30% |
| 3 Years | -78.40% |
| 5 Years | -95.58% |
| 10 Years | -93.46% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $1.57 | 125,400 |
| 2026-07-16 | $1.62 | 131,300 |
| 2026-07-15 | $1.61 | 101,000 |
| 2026-07-14 | $1.58 | 283,000 |
| 2026-07-13 | $1.64 | 84,000 |
| 2026-07-10 | $1.71 | 223,500 |
| 2026-07-09 | $1.67 | 273,500 |
| 2026-07-08 | $1.67 | 397,400 |
| 2026-07-07 | $1.68 | 540,200 |
| 2026-07-06 | $1.77 | 481,800 |
| 2026-07-02 | $1.72 | 110,400 |
| 2026-07-01 | $1.78 | 156,300 |
| 2026-06-30 | $1.69 | 142,400 |
| 2026-06-29 | $1.65 | 102,200 |
| 2026-06-26 | $1.67 | 112,900 |
| 2026-06-25 | $1.63 | 92,100 |
| 2026-06-24 | $1.62 | 68,800 |
| 2026-06-23 | $1.57 | 102,200 |
| 2026-06-22 | $1.57 | 133,000 |
| 2026-06-18 | $1.60 | 281,700 |
About Nyxoah SA
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
đ° Latest News
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day
MarketBeat âĸ 2026-07-10T23:02:20ZNyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution
Simply Wall St. âĸ 2026-07-08T09:15:02ZNyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns
Simply Wall St. âĸ 2026-06-24T04:30:59ZWhy Is NYXH Stock Falling Today?
Stocktwits âĸ 2026-06-05T16:58:40ZNyxoah SA (NYXH) Q1 2026 Earnings Call Highlights: Strong U.S. ...
GuruFocus.com âĸ 2026-05-13T05:01:47ZNyxoah Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-13T01:09:09ZNyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-12T23:00:03ZNyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks âĸ 2026-05-05T14:00:06ZHow The Nyxoah (ENXTBR:NYXH) Narrative Is Shifting With CMS Codes And Trimmed Targets
Simply Wall St. âĸ 2026-05-05T03:18:09ZBaird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87
Insider Monkey âĸ 2026-04-04T12:16:30Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $610,984 | $135,011 | $386,728 | $151,030 |
| Cost Of Revenue | $4,226,545 | $1,775,744 | $1,894,737 | $1,315,790 |
| Total Revenue | $11,464,531 | $5,172,769 | $4,974,829 | $3,528,604 |
| Operating Revenue | $11,464,531 | $5,172,769 | $4,974,829 | $3,528,604 |
| Expenses | ||||
| Interest Expense | $1,934,783 | $1,013,730 | $248,284 | $271,167 |
| Total Expenses | $106,363,848 | $72,459,957 | $56,578,949 | $40,712,816 |
| Rent Expense Supplemental | $564,073 | $731,121 | $362,700 | $503,433 |
| Other Income Expense | $-2,195,652 | $2,034,325 | $-1,058,352 | $3,299,771 |
| Net Non Operating Interest Income Expense | $-4,826,087 | $685,355 | $1,567,506 | $-504,577 |
| Total Other Finance Cost | $4,989,703 | $1,163,616 | $1,125,858 | $659,039 |
| Interest Expense Non Operating | $1,934,783 | $1,013,730 | $248,284 | $271,167 |
| Operating Expense | $102,137,303 | $70,684,213 | $54,684,212 | $39,397,027 |
| Other Operating Expenses | $-1,506,865 | $-1,153,318 | $-622,426 | $-323,799 |
| General And Administrative Expense | $53,131,581 | $31,094,967 | $23,621,282 | $20,527,461 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-103,072,086 | $-67,775,746 | $-49,441,649 | $-35,726,546 |
| Net Interest Income | $-4,826,087 | $685,355 | $1,567,506 | $-504,577 |
| Interest Income | $2,098,398 | $2,862,700 | $2,941,648 | $425,629 |
| Normalized Income | $-101,425,347 | $-69,301,490 | $-48,417,543 | $-38,201,374 |
| Net Income From Continuing And Discontinued Operation | $-103,072,086 | $-67,775,746 | $-49,441,649 | $-35,726,546 |
| Total Operating Income As Reported | $-95,520,598 | $-67,287,188 | $-51,604,121 | $-37,184,212 |
| Net Income Common Stockholders | $-103,072,086 | $-67,775,746 | $-49,441,649 | $-35,726,546 |
| Net Income | $-103,072,086 | $-67,775,746 | $-49,441,649 | $-35,726,546 |
| Net Income Including Noncontrolling Interests | $-103,072,086 | $-67,775,746 | $-49,441,649 | $-35,726,546 |
| Net Income Continuous Operations | $-103,072,086 | $-67,775,746 | $-49,441,649 | $-35,726,546 |
| Pretax Income | $-101,917,624 | $-64,567,508 | $-51,094,967 | $-34,389,017 |
| Special Income Charges | $-624,714 | $0 | $0 | - |
| Interest Income Non Operating | $2,098,398 | $2,862,700 | $2,941,648 | $425,629 |
| Operating Income | $-94,899,317 | $-67,287,188 | $-51,604,121 | $-37,184,212 |
| Depreciation Amortization Depletion Income Statement | $1,514,874 | $1,469,108 | $1,192,220 | $1,045,767 |
| Depreciation And Amortization In Income Statement | $1,514,874 | $1,469,108 | $1,192,220 | $1,045,767 |
| Gross Profit | $7,237,987 | $3,397,025 | $3,080,092 | $2,212,815 |
| Per Share | ||||
| Diluted EPS | $-2.70 | $-2.07 | $-1.77 | $-1.38 |
| Basic EPS | $-2.70 | $-2.07 | $-1.77 | $-1.38 |
| Other | ||||
| Tax Effect Of Unusual Items | $-548,913 | $508,581 | $-34,246 | $824,943 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-92,656,754 | $-62,478,263 | $-47,088,102 | $-35,207,095 |
| Total Unusual Items | $-2,195,652 | $2,034,325 | $-1,058,352 | $3,299,771 |
| Total Unusual Items Excluding Goodwill | $-2,195,652 | $2,034,325 | $-1,058,352 | $3,299,771 |
| Reconciled Depreciation | $5,130,435 | $3,109,840 | $2,700,229 | $2,210,526 |
| EBITDA (Bullshit earnings) | $-94,852,406 | $-60,443,938 | $-48,146,455 | $-31,907,324 |
| EBIT | $-99,982,841 | $-63,553,778 | $-50,846,684 | $-34,117,850 |
| Diluted Average Shares | $43,600,713 | $37,465,863 | $32,000,164 | $29,550,493 |
| Basic Average Shares | $43,600,713 | $37,465,863 | $32,000,164 | $29,550,493 |
| Diluted NI Availto Com Stockholders | $-103,072,086 | $-67,775,746 | $-49,441,649 | $-35,726,546 |
| Tax Provision | $1,154,462 | $3,208,238 | $-1,653,318 | $1,337,529 |
| Gain On Sale Of Ppe | $-185,355 | $0 | $0 | - |
| Other Special Charges | $-136,156 | - | - | - |
| Write Off | $575,515 | $0 | $0 | - |
| Gain On Sale Of Security | $-1,570,938 | $2,034,325 | $-1,058,352 | $3,299,771 |
| Research And Development | $48,997,713 | $39,273,457 | $30,493,136 | $18,147,598 |
| Selling General And Administration | $53,131,581 | $31,094,967 | $23,621,282 | $20,527,461 |
| Other Gand A | $21,935,928 | $16,728,834 | $11,897,026 | $9,085,813 |
| Insurance And Claims | $493,135 | $584,668 | $1,127,002 | $1,720,824 |
| Rent And Landing Fees | $564,073 | $731,121 | $362,700 | $503,433 |
| Salaries And Wages | $30,138,445 | $13,050,344 | $10,234,554 | $9,217,392 |
Fetched: 2026-07-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,120,137 | $71,937,073 | $58,826,089 | $91,935,930 |
| Total Assets | $135,550,348 | $181,242,569 | $142,056,069 | $167,129,297 |
| Total Non Current Assets | $65,512,588 | $69,019,453 | $63,851,261 | $52,415,334 |
| Non Current Deferred Assets | $99,542 | $86,957 | $64,073 | $53,776 |
| Non Current Deferred Taxes Assets | $99,542 | $86,957 | $64,073 | $53,776 |
| Non Current Accounts Receivable | $1,861,556 | $1,721,968 | $1,334,096 | $197,941 |
| Financial Assets | $104,119 | $128,146 | - | - |
| Goodwill And Other Intangible Assets | $57,331,810 | $57,644,167 | $53,327,233 | $45,734,555 |
| Other Intangible Assets | $57,331,810 | $57,644,167 | $53,327,233 | $45,734,555 |
| Current Assets | $70,037,760 | $112,223,116 | $78,204,808 | $114,713,963 |
| Hedging Assets Current | $4,577 | $0 | $392,449 | $1,144 |
| Current Deferred Assets | $758,581 | $1,050,343 | - | - |
| Prepaid Assets | $351,259 | $839,817 | - | - |
| Inventory | $5,331,808 | $5,395,881 | $3,792,906 | $1,009,153 |
| Receivables | $8,670,481 | $7,048,055 | $6,438,215 | $3,703,661 |
| Other Receivables | $1,028,604 | $1,224,256 | $1,385,584 | $878,719 |
| Taxes Receivable | $1,630,435 | $1,954,233 | $1,897,025 | $1,151,030 |
| Accounts Receivable | $6,011,442 | $3,869,565 | $3,155,607 | $1,673,913 |
| Cash Cash Equivalents And Short Term Investments | $54,921,055 | $97,889,019 | $66,073,229 | $108,530,896 |
| Cash And Cash Equivalents | $34,326,088 | $39,114,418 | $24,725,401 | $20,466,820 |
| Cash Equivalents | $25,321,511 | $32,288,331 | $10,478,261 | $41,190 |
| Cash Financial | $9,004,577 | $6,826,087 | $14,247,140 | $20,425,630 |
| Other Current Assets | - | $1,894,737 | $1,508,009 | $1,469,108 |
| Debt | ||||
| Net Debt | $10,363,845 | - | - | - |
| Total Debt | $46,310,070 | $25,918,765 | $14,535,470 | $13,596,110 |
| Long Term Debt And Capital Lease Obligation | $19,114,417 | $24,355,836 | $13,145,309 | $12,328,376 |
| Long Term Debt | $18,385,584 | $21,424,486 | $9,580,092 | $9,369,566 |
| Current Debt And Capital Lease Obligation | $27,195,653 | $1,562,929 | $1,390,160 | $1,267,735 |
| Current Debt | $26,304,349 | $283,753 | $416,476 | $445,080 |
| Other Current Borrowings | $26,304,349 | $283,753 | $416,476 | $445,080 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $79,338,676 | $51,661,329 | $29,902,747 | $29,458,811 |
| Total Non Current Liabilities Net Minority Interest | $23,322,655 | $27,028,605 | $13,377,575 | $12,395,881 |
| Derivative Product Liabilities | $1,831,808 | - | - | - |
| Non Current Deferred Liabilities | $779,176 | $561,785 | $10,297 | $0 |
| Non Current Deferred Taxes Liabilities | $0 | $21,739 | $10,297 | $0 |
| Current Liabilities | $56,016,020 | $24,632,724 | $16,525,172 | $17,062,930 |
| Other Current Liabilities | $1,726,545 | $1,665,904 | $331,808 | $10,297 |
| Current Deferred Liabilities | $1,022,883 | $133,867 | $0 | - |
| Payables And Accrued Expenses | $25,439,360 | $20,236,843 | $13,898,170 | $15,084,669 |
| Payables | $10,701,373 | $9,228,833 | $6,967,964 | $6,473,684 |
| Total Tax Payable | $4,788,330 | $4,939,359 | $2,274,600 | $4,180,778 |
| Accounts Payable | $5,913,044 | $4,289,474 | $4,693,364 | $2,143,021 |
| Other Non Current Liabilities | - | $966,819 | - | $1,144 |
| Other Payable | - | - | $228,833 | $149,886 |
| Equity | ||||
| Common Stock Equity | $56,211,672 | $129,581,240 | $112,153,322 | $137,670,485 |
| Total Equity Gross Minority Interest | $56,211,672 | $129,581,240 | $112,153,322 | $137,670,485 |
| Stockholders Equity | $56,211,672 | $129,581,240 | $112,153,322 | $137,670,485 |
| Other Equity Interest | $14,181,923 | $10,640,733 | $8,765,447 | $6,458,810 |
| Gains Losses Not Affecting Retained Earnings | $1,286,041 | $1,045,767 | $156,751 | $201,373 |
| Other Equity Adjustments | $1,286,041 | $1,045,767 | $156,751 | $201,373 |
| Retained Earnings | $-350,147,610 | $-249,124,723 | $-184,014,881 | $-135,254,009 |
| Other | ||||
| Ordinary Shares Number | $49,229,361 | $42,822,959 | $32,807,764 | $29,572,403 |
| Share Issued | $49,229,361 | $42,822,959 | $32,807,764 | $29,572,403 |
| Tangible Book Value | $-1,120,137 | $71,937,073 | $58,826,089 | $91,935,930 |
| Invested Capital | $100,901,605 | $151,289,479 | $122,149,890 | $147,485,131 |
| Working Capital | $14,021,740 | $87,590,392 | $61,679,636 | $97,651,033 |
| Capital Lease Obligations | $1,620,137 | $4,210,526 | $4,538,902 | $3,781,465 |
| Total Capitalization | $74,597,257 | $151,005,726 | $121,733,414 | $147,040,051 |
| Additional Paid In Capital | $383,448,526 | $359,662,484 | $281,609,850 | $261,184,220 |
| Capital Stock | $7,442,792 | $7,356,980 | $5,636,156 | $5,080,092 |
| Common Stock | $7,442,792 | $7,356,980 | $5,636,156 | $5,080,092 |
| Non Current Deferred Revenue | $779,176 | $540,046 | $0 | - |
| Long Term Capital Lease Obligation | $728,833 | $2,931,350 | $3,565,218 | $2,958,810 |
| Long Term Provisions | $1,597,254 | $1,144,165 | $211,670 | $67,506 |
| Current Deferred Revenue | $1,022,883 | $133,867 | $0 | - |
| Current Capital Lease Obligation | $891,304 | $1,279,176 | $973,684 | $822,654 |
| Pensionand Other Post Retirement Benefit Plans Current | $631,579 | $1,033,181 | $905,034 | $700,229 |
| Current Accrued Expenses | $14,737,987 | $11,008,010 | $6,930,206 | $8,610,984 |
| Net PPE | $6,115,561 | $9,438,215 | $9,125,858 | $6,429,062 |
| Accumulated Depreciation | $-5,653,318 | $-6,509,154 | $-4,648,742 | $-3,164,760 |
| Gross PPE | $11,768,879 | $15,947,369 | $13,774,600 | $9,593,822 |
| Leases | $4,709,382 | $2,100,687 | $1,503,433 | $805,492 |
| Construction In Progress | $34,325 | $2,584,668 | $2,351,259 | $821,510 |
| Other Properties | $2,041,190 | $2,176,201 | $1,717,391 | $1,430,206 |
| Machinery Furniture Equipment | $3,038,902 | $3,298,627 | $2,934,783 | $2,390,160 |
| Buildings And Improvements | $1,945,080 | $5,787,186 | $5,267,735 | $4,146,453 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,709,382 | $1,247,140 | $521,739 | $324,943 |
| Work In Process | $2,117,849 | $2,913,044 | $1,750,572 | $114,416 |
| Raw Materials | $1,504,577 | $1,235,698 | $1,520,595 | $569,794 |
| Other Short Term Investments | $20,594,966 | $58,774,602 | $41,347,828 | $88,064,076 |
| Employee Benefits | - | $0 | $10,297 | $0 |
| Non Current Pension And Other Postretirement Benefit Plans | - | $0 | $10,297 | $0 |
| Preferred Stock | - | - | - | $0 |
Fetched: 2026-07-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-83,235,701 | $-63,270,025 | $-63,775,746 | $-51,607,553 |
| Operating Activities | ||||
| Operating Cash Flow | $-78,923,344 | $-56,322,656 | $-51,233,411 | $-32,901,603 |
| Cash Flow From Continuing Operating Activities | $-78,923,344 | $-56,322,656 | $-51,233,411 | $-32,901,603 |
| Operating Gains Losses | $1,756,293 | $-2,034,325 | $1,058,352 | $-3,299,771 |
| Investing Activities | ||||
| Capital Expenditure | $-4,312,357 | $-6,947,369 | $-12,542,335 | $-18,705,950 |
| Investing Cash Flow | $32,416,477 | $-18,678,490 | $36,625,859 | $-102,913,047 |
| Cash Flow From Continuing Investing Activities | $32,416,477 | $-18,678,490 | $36,625,859 | $-102,913,047 |
| Capital Expenditure Reported | $-3,391,304 | $-5,614,417 | $-9,681,923 | $-17,692,220 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $23,871,854 | $79,773,458 | $20,980,550 | $291,762 |
| Financing Cash Flow | $43,600,688 | $88,602,978 | $19,288,330 | $-1,124,714 |
| Cash Flow From Continuing Financing Activities | $43,600,688 | $88,602,978 | $19,288,330 | $-1,124,714 |
| Net Other Financing Charges | $-3,719,680 | $-299,771 | $-58,352 | $-42,334 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $23,871,854 | $79,773,458 | $20,980,550 | $291,762 |
| Common Stock Issuance | $23,871,854 | $79,773,458 | $20,980,550 | $291,762 |
| Other | ||||
| Repayment Of Debt | $-1,501,144 | $-1,744,851 | $-1,414,188 | $-1,225,401 |
| Issuance Of Debt | $25,743,708 | $11,441,648 | $0 | $0 |
| End Cash Position | $34,326,088 | $39,114,418 | $24,725,401 | $20,466,820 |
| Beginning Cash Position | $39,114,418 | $24,725,401 | $20,466,820 | $155,044,628 |
| Effect Of Exchange Rate Changes | $-1,882,151 | $787,185 | $-422,197 | $2,361,556 |
| Changes In Cash | $-2,906,179 | $13,601,831 | $4,680,778 | $-136,939,364 |
| Interest Paid Cff | $-794,050 | $-567,506 | $-219,680 | $-148,741 |
| Net Issuance Payments Of Debt | $24,242,564 | $9,696,797 | $-1,414,188 | $-1,225,401 |
| Net Long Term Debt Issuance | $24,242,564 | $9,696,797 | $-1,414,188 | $-1,225,401 |
| Long Term Debt Payments | $-1,501,144 | $-1,744,851 | $-1,414,188 | $-1,225,401 |
| Long Term Debt Issuance | $25,743,708 | $11,441,648 | $0 | $0 |
| Interest Received Cfi | $2,462,243 | $2,584,668 | $2,643,021 | $125,858 |
| Net Investment Purchase And Sale | $34,263,159 | $-14,323,799 | $46,525,173 | $-84,332,955 |
| Sale Of Investment | $82,375,289 | $97,610,987 | $138,078,952 | $33,081,237 |
| Purchase Of Investment | $-48,112,130 | $-111,934,787 | $-91,553,779 | $-117,414,192 |
| Net PPE Purchase And Sale | $-917,620 | $-1,324,943 | $-2,860,412 | $-1,013,730 |
| Sale Of PPE | $3,432 | $8,009 | $0 | $0 |
| Purchase Of PPE | $-921,053 | $-1,332,952 | $-2,860,412 | $-1,013,730 |
| Taxes Refund Paid | $-1,193,364 | $-612,128 | $-902,746 | $-469,108 |
| Change In Working Capital | $6,145,309 | $3,389,016 | $-3,997,712 | $98,398 |
| Change In Payables And Accrued Expense | $8,529,749 | $5,851,259 | $548,055 | $703,661 |
| Change In Payable | $8,529,749 | $5,851,259 | $548,055 | $703,661 |
| Change In Inventory | $64,073 | $-1,602,975 | $-2,783,753 | $-613,272 |
| Change In Receivables | $-2,448,513 | $-859,268 | $-1,762,014 | $8,009 |
| Other Non Cash Items | $3,153,318 | $-1,082,380 | $-2,231,121 | $-185,355 |
| Stock Based Compensation | $5,590,389 | $4,540,046 | $2,987,414 | $3,086,957 |
| Unrealized Gain Loss On Investment Securities | $58,352 | $0 | $0 | - |
| Provisionand Write Offof Assets | $431,350 | $934,783 | $247,140 | $42,334 |
| Asset Impairment Charge | $1,922,197 | $0 | $0 | - |
| Depreciation Amortization Depletion | $5,130,435 | $3,109,840 | $2,700,229 | $2,210,526 |
| Depreciation And Amortization | $5,130,435 | $3,109,840 | $2,700,229 | $2,210,526 |
| Amortization Cash Flow | $2,551,488 | $1,105,263 | $1,100,687 | $930,206 |
| Amortization Of Intangibles | $2,551,488 | $1,105,263 | $1,100,687 | $930,206 |
| Depreciation | $2,578,947 | $2,004,577 | $1,599,542 | $1,280,320 |
| Gain Loss On Investment Securities | $-1,814,645 | $461,098 | $-289,474 | $3,112,128 |
| Net Foreign Currency Exchange Gain Loss | $3,385,584 | $-2,495,423 | $1,347,826 | $-6,411,900 |
| Gain Loss On Sale Of PPE | $185,355 | $0 | $0 | - |
| Net Income From Continuing Operations | $-101,917,624 | $-64,567,508 | $-51,094,967 | $-34,389,017 |
| Interest Received Cfo | - | $0 | $0 | $3,432 |
Fetched: 2026-07-16